Press release

SimpleTrials Achieves Unprecedented Growth with 85% YOY Increase in 2023

businesswire,
0
Sponsored by Businesswire

Trial By Fire Solutions, makers of SimpleTrials and a leading provider of cloud-based Clinical Trial Management Systems (CTMS) and electronic Trial Master File (eTMF) solutions, today announced a remarkable 85% year-over-year growth in 2023. The outlook for 2024 year-to-date is on track to be remarkable again. The growth highlights the company’s continued global adoption, with significant customer growth across the European Union (EU) and Asia-Pacific (APAC) regions.

SimpleTrials‘ rapid rise reflects the global demand for cost-effective, scalable solutions that simplify the clinical trial management process for Biotech, Pharma, Medical Devices, Contract Research Organizations (CROs), and Site Management organizations (CROs). A key driver of this success has been the growing demand for SimpleTrials‘ On-Demand Subscription model, which allows organizations to seamlessly onboard and start managing trials without the traditional complexity associated with vendor onboarding.

The SimpleTrials On-Demand Subscription model, designed to streamline the entire vendor onboarding process, has been particularly attractive to customers seeking quick implementation, flexibility, and scalability. By offering immediate access to a full-featured CTMS and eTMF platform without lengthy implementation, the model has reduced the time to days instead of months required to start using the platform, providing organizations with faster returns on their investment.

  • Ease of Adoption: SimpleTrials’ intuitive user interface and customizable features make it easy for organizations to get started quickly. This user-friendliness has been pivotal in attracting new customers from the EU and APAC regions, where ease of implementation and compliance with regional regulations are critical.
  • Streamlined Onboarding: The platform’s On-Demand model eliminates complex vendor onboarding procedures, enabling users to subscribe and begin managing clinical trials with minimal effort. This has been a key differentiator in SimpleTrials’ global growth, particularly for small- and medium-sized Biotech, Medical Device, Contract Research Organizations (CROs), and Site Management organizations (CROs) that prioritize agility and cost-efficiency.
  • Platform Enhancements: SimpleTrials innovations are fit-for-purpose enhancements that maintain compliance and prioritize the needs of clinical study users.

“At SimpleTrials, we are thrilled to see the global adoption of our platform, particularly in the EU and APAC regions, where clinical research organizations are increasingly recognizing the value of flexible, subscription-based solutions,” said Jon Cecchettini, Co-Founder/Chief Technology Officer at SimpleTrials. “Our growth is a testament to the success of our On-Demand Subscription model, which has made it easier than ever for organizations to access and benefit from our full-featured CTMS and eTMF solution.”

As SimpleTrials looks ahead to 2025 and beyond, the company plans to continue expanding its global footprint with new features and integrations designed to further simplify clinical trial operations, ensure compliance with regional regulatory standards, and maintain inspection readiness.